SRx Health Solutions (SRXH) Common Equity (2011 - 2025)

SRx Health Solutions has reported Common Equity for 15 years, with the latest figure at $3.5 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity rose 105.53% year-over-year to $3.5 million; the trailing twelve-month figure through Dec 2025 stood at $3.5 million (up 105.53% YoY), and the FY2025 full-year result was $3.5 million, up 105.53% from the prior year.
• Common Equity for Q4 2025 stood at $3.5 million, up from $407000.0 in the prior quarter.
• The five-year high for Common Equity was $62.7 million in Q3 2021, with the low at -$63.7 million in Q4 2024.
• Historically, Common Equity has averaged $5.3 million across 5 years, with a median of $5.7 million in 2025.
• Annual changes were most pronounced in 2024 — Common Equity plunged 2260.57% — and 2025, when it jumped 628.64%.
• SRx Health Solutions' Common Equity stood at $57.9 million in 2021, then tumbled by 62.8% to $21.5 million in 2022, then tumbled by 86.31% to $2.9 million in 2023, then sank by 2260.57% to -$63.7 million in 2024, then jumped by 105.53% to $3.5 million in 2025.
• The last three Common Equity figures came in at $3.5 million (Q4 2025), $407000.0 (Q3 2025), and -$45.9 million (Q2 2025), per Business Quant data.